title: Bioorthogonal reaction pairs enable simultaneous, selective, multi-target imaging.
authors.affiliation: Center for Systems Biology, Massachusetts General Hospital/Harvard Medical School, 185 Cambridge Street, Suite 5.210, Boston, MA 02114, USA.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Karver
authors.forename: Ralph
authors.initials: R
authors.lastname: Weissleder
authors.forename: Scott A
authors.initials: SA
authors.lastname: Hilderbrand
mesh_terms: D000480:Alkynes / Q000737:chemistry; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized / Q000737:chemistry / Q000494:pharmacology; D001386:Azides / Q000737:chemistry; D045744:Cell Line, Tumor; D000068818:Cetuximab; D018920:Coculture Techniques; D003287:Contrast Media / Q000737:chemistry* / Q000494:pharmacology; D066246:ErbB Receptors / Q000737:chemistry / Q000378:metabolism; D005456:Fluorescent Dyes / Q000737:chemistry; D006801:Humans; D008856:Microscopy, Fluorescence; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000737:chemistry / Q000378:metabolism; D000068878:Trastuzumab
chemical_list: D000480:Alkynes; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001386:Azides; D000068818:Cetuximab; D003287:Contrast Media; D066246:ErbB Receptors; D005456:Fluorescent Dyes; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human